Health Sciences Enters Into LOI With The Healing Center of Montana to Acquire Two Medical Marijuana Licenses

INDIAN HARBOR BEACH, FL--(Marketwire - December 15, 2009) - Health Sciences Group, Inc. (PINKSHEETS: HESG) would like to announce that it has entered into a letter of intent with The Healing Center of Montana to purchase two operating licenses for medical marijuana collectives in Park County, Montana and Lake County, Montana. This transaction is contingent with standard due diligence and anticipated to finalize before the end of the year.

The Healing Center of Montana, owned and operated by Mike Smith, is the largest medical marijuana operation in the State of Montana and also has a presence in Colorado. Mike Smith has been in the Montana medical marijuana business since the state went legal.

"We anticipate this transaction to move very quickly, by the end of the month if not sooner. Contracts and agreements are going back and forth between the companies right now," stated Thomas Gaffney, CEO of Health Sciences Group, Inc.

Gaffney continues, "Health Sciences Group intends on being the first public medical marijuana company to derive actual revenues from medical marijuana operations. Although The Healing Center is non-profit, these two new locations would be for profit under a management agreement."

Montana, unlike California, allows collectives to be for profit.

ABOUT HEALTH SCIENCES GROUP, INC.

Health Sciences Group, Inc. is a provider of health and wellness services to consumers, physicians and other healthcare professionals through its website, www.igohealthy.org, and health focused publications. The Health Sciences network consists of its public website, www.igohealthy.org, and iGoHealthy Magazine. The Company operates in three segments: Online Services, Publishing and Other Services. The Company is recently exploring options of corporate growth within the Legal Medical Marijuana Industry.

FORWARD-LOOKING DISCLAIMER

This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Health Sciences Group, Inc. to be materially different from the statements made herein. Investors are highly advised to seek professional advice and conduct a complete due diligence regarding this, or any other company being considered for investment purposes. Investing in securities, particularly in issues priced at less than $1 per share, involves substantial risk and may result in a partial or complete loss of investment capital. Health Sciences Group, Inc., its subsidiaries, officers and employees cannot guarantee the completeness or accuracy of the information contained in company press releases or other company communications. Press releases and communications issued by the company should not be interpreted as an offer to sell or a solicitation to buy company stock.

Investors are highly advised to seek professional advice and conduct a complete due diligence regarding this, or any other company being considered for investment purposes. Investing in securities, particularly in issues priced at less than $1 per share, involves substantial risk and may result in a partial or complete loss of investment capital. Health Sciences Group, Inc., its subsidiaries, officers and employees cannot guarantee the completeness or accuracy of the information contained in company press releases or other company communications. Press releases and communications issued by the company should not be interpreted as an offer to sell or a solicitation to buy company stock.

Contact Information: CONTACT: Health Sciences Group, Inc. Investor Relations Frank Godleski IR Representative Email Contact: